Skip to main content

Biostage’s Cellspan Implant an Orphan Drug for restoration of esophagus

The FDA designates Biostage’s (BSTG +30%) Cellspan Esophageal Implantan Orphan Drug for restoring the structure and function of the esophagus due to cancer, injury or congenital abnormalities.

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino